Androstenedione at Dr. Essa Lab

Androstenedione at Dr. Essa Lab

Androstenedione is a major 19-carbon steroid hormone precursor synthesized primarily within the adrenal cortex and the gonads. As an essential intermediate in the steroidogenic pathway, it is produced from 17-hydroxyprogesterone via the action of the enzyme 17,20-lyase, or from dehydroepiandrosterone (DHEA) through the catalytic activity of 3-beta-hydroxysteroid dehydrogenase. Once synthesized, androstenedione is secreted into the systemic circulation, where it serves as the primary substrate for conversion into more potent androgens, such as testosterone, and estrogens, including estrone and estradiol, in peripheral tissues. The quantitative measurement of serum androstenedione is a cornerstone in clinical endocrinology, providing invaluable insights into the functional status of the adrenal glands and the ovaries. At Dr. Essa Lab, the premier diagnostic network in Karachi, Pakistan, this test is performed using state-of-the-art chemiluminescent immunoassay (CLIA) technology. This advanced methodology ensures high analytical sensitivity and specificity, allowing for the precise detection of even minute hormonal fluctuations. Evaluating androstenedione levels is clinically vital for diagnosing and managing a wide spectrum of endocrine disorders, including hyperandrogenic states, adrenal enzyme deficiencies, and hormone-producing neoplasms. By choosing Dr. Essa Lab, patients and clinicians benefit from a highly reliable diagnostic process that combines cutting-edge laboratory automation with the clinical expertise of senior pathologists. This test plays an indispensable role in identifying the root causes of reproductive dysfunction, metabolic disturbances, and abnormal physical development, thereby guiding targeted therapeutic interventions and improving patient outcomes across Pakistan.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy and clinical utility of your Androstenedione test results at Dr. Essa Lab, strict adherence to patient preparation guidelines is essential. Because hormone levels are highly dynamic and influenced by physiological rhythms, medications, and metabolic states, please follow these instructions carefully:

• Diurnal Variation and Timing: Serum androstenedione levels exhibit a distinct diurnal variation, peaking in the early morning hours. Therefore, it is highly recommended that blood collection be performed between 6:00 AM and 10:00 AM.
• Menstrual Cycle Timing: For female patients of reproductive age, the timing of the test relative to the menstrual cycle is critical. Unless otherwise directed by your physician, the specimen should ideally be collected during the early follicular phase (typically days 2 to 5 of the menstrual cycle) or exactly one week before or after the expected onset of menstruation to establish a reliable clinical baseline.
• Fasting Guidelines: While absolute fasting is not always mandatory, a fasting period of 8 to 12 hours prior to venipuncture is highly preferred. This minimizes potential dietary lipemia, which can interfere with the optical detection systems of automated immunoassay analyzers.
• Medication Disclosure: Inform your healthcare provider and the laboratory staff at Dr. Essa Lab of all medications, supplements, and hormonal therapies you are currently taking. Specifically, glucocorticoids, oral contraceptives, spironolactone, and anabolic steroids can significantly alter endogenous androgen levels and must be documented.
• Avoid Strenuous Exercise: Refrain from vigorous physical activity or intense exercise for at least 24 hours before the test, as physical stress can acutely stimulate the hypothalamic-pituitary-adrenal (HPA) axis, leading to transiently elevated adrenal androgen secretion.
• Hydration: Maintain normal hydration by drinking plain water before the procedure. Proper hydration ensures adequate venous volume, making the venipuncture process smoother and more comfortable.

During the Procedure

The Androstenedione test is a straightforward laboratory investigation involving a standard venipuncture. When you arrive at one of the modern diagnostic centers of Dr. Essa Lab in Karachi, you will be welcomed by professional staff who prioritize your comfort and safety. The entire procedure is completed in a few simple steps:

• Patient Identification and Verification: The phlebotomist will verify your identity using your registration details and confirm that you have followed the necessary preparation steps, such as morning timing and fasting.
• Positioning: You will be seated comfortably in a specialized phlebotomy chair. You will be asked to extend your arm, resting it on a supportive armrest to ensure stability during the blood draw.
• Site Selection and Cleansing: The phlebotomist will inspect your antecubital fossa to locate a accessible vein. Once selected, the area is thoroughly cleansed with a 70% isopropyl alcohol swab using a circular motion from the center outward to ensure complete sterility.
• Tourniquet Application: A soft elastic tourniquet is applied a few inches above the selected site to temporarily restrict venous blood flow, causing the vein to engorge and become more visible and palpable.
• Venipuncture: Using a sterile, single-use, fine-gauge needle attached to a vacuum collection system, the phlebotomist will gently insert the needle into the vein. You may feel a brief, mild pinch or stinging sensation as the needle enters the skin.
• Sample Collection: Blood is drawn directly into a serum separator tube (SST), which contains a clot activator and a barrier gel. Once the required volume of blood is collected, the tourniquet is released, and the needle is smoothly withdrawn.
• Post-Puncture Care: A sterile cotton ball or gauze pad is immediately applied to the puncture site with gentle pressure to promote hemostasis and prevent hematoma formation. A small adhesive bandage is then placed over the site.
• Safety and Comfort: The entire venipuncture process takes less than five minutes. Dr. Essa Lab maintains the highest standards of biosafety, utilizing vacuum-sealed collection tubes and disposable materials to eliminate any risk of cross-contamination.

When is an Androstenedione Test Performed?

Evaluating Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome (PCOS) is a highly prevalent endocrine disorder affecting women of reproductive age, characterized by ovulatory dysfunction, polycystic ovarian morphology, and clinical or biochemical hyperandrogenism. Physicians frequently request an Androstenedione test at Dr. Essa Lab when a patient presents with symptoms such as irregular or absent menstrual periods, persistent acne, and hirsutism. In PCOS, hyperpulsatile secretion of luteinizing hormone (LH) stimulates the ovarian theca cells to overproduce androstenedione. Measuring this hormone, alongside testosterone and DHEA-S, is crucial for confirming biochemical hyperandrogenism, establishing an accurate diagnosis according to the Rotterdam criteria, and ruling out other confounding endocrine conditions.

Diagnosing Congenital Adrenal Hyperplasia (CAH)

Congenital Adrenal Hyperplasia (CAH) comprises a group of inherited autosomal recessive disorders caused by deficiencies in enzymes essential for cortisol biosynthesis in the adrenal cortex. The most common form is 21-hydroxylase deficiency. The lack of cortisol removes the negative feedback inhibition on the pituitary gland, resulting in excessive secretion of adrenocorticotropic hormone (ACTH). This chronic overstimulation drives bilateral adrenal hyperplasia and shunts steroid precursors into the androgenic pathway, leading to massive overproduction of androstenedione and 17-hydroxyprogesterone. Clinicians order this test to diagnose classic CAH in newborns presenting with ambiguous genitalia or salt-wasting crises, as well as to identify non-classic CAH in adolescents and young adults.

Investigating Virilization and Hirsutism

Virilization is a clinical syndrome in females characterized by the development of pronounced male secondary sexual characteristics due to severe androgen excess. Symptoms include a deepening of the voice, clitomegaly, temporal hair thinning or male-pattern baldness, increased muscle mass, and loss of female body fat distribution. Hirsutism, while often less severe, also indicates androgen excess. When these symptoms appear, particularly if they develop rapidly or progressively, physicians urgently request an Androstenedione test at Dr. Essa Lab. This investigation helps determine whether the source of excess androgens is adrenal or ovarian in origin, allowing clinicians to differentiate between benign functional hyperandrogenism and potentially life-threatening androgen-secreting neoplasms.

Assessing Adrenal and Ovarian Tumors

Androgen-producing tumors, though rare, can arise in either the adrenal glands or the ovaries. These neoplasms operate independently of normal physiological feedback loops, continuously secreting massive quantities of androgens. A sudden, severe onset of virilizing signs in a female, or rapid virilization in a child, is a strong clinical indication for an Androstenedione test. Extremely elevated concentrations of serum androstenedione, often exceeding several times the upper limit of normal, strongly point toward a neoplastic source. This diagnostic insight is critical for initiating prompt imaging studies, such as CT or MRI scans, and planning surgical intervention.

Evaluating Premature Adrenarche

Premature adrenarche refers to the early increase in adrenal androgen production, typically occurring in girls under the age of 8 and boys under the age of 9, without the concurrent activation of the hypothalamic-pituitary-gonadal axis. Affected children present with the early appearance of pubic or axillary hair, adult-type body odor, and mild acne. Pediatric endocrinologists utilize the Androstenedione test at Dr. Essa Lab to evaluate these patients. Measuring androstenedione helps confirm that the physical changes are due to early adrenal maturation rather than central precocious puberty, congenital adrenal hyperplasia, or an androgen-secreting tumor, ensuring appropriate clinical monitoring and parental reassurance.

What Does an Androstenedione Test Detect?

The quantitative analysis of serum androstenedione at Dr. Essa Lab is highly sensitive and capable of detecting a wide range of physiological variations and pathological conditions. By measuring the concentration of this hormone, clinical pathologists and endocrinologists can identify and differentiate several complex disorders:

• Classic 21-Hydroxylase Deficiency: Detects severe elevations of androstenedione in newborns and infants, confirming classic CAH.
• Non-Classic Congenital Adrenal Hyperplasia: Identifies moderate elevations of androstenedione in older children and young adults with late-onset enzyme deficiencies.
• Polycystic Ovary Syndrome (PCOS): Detects elevated ovarian androgen production, confirming biochemical hyperandrogenism in symptomatic females.
• Adrenocortical Carcinoma: Detects extremely high, autonomous secretion of adrenal androgens associated with malignant adrenal tumors.
• Benign Adrenal Adenoma: Identifies elevated adrenal androgen levels caused by non-cancerous, hormone-secreting adrenal nodules.
• Sertoli-Leydig Cell Tumors: Detects marked elevations of ovarian-derived androstenedione caused by rare, androgen-producing ovarian neoplasms.
• Ovarian Stromal Hyperthecosis: Identifies significant androgen overproduction in postmenopausal women, characterized by luteinized stromal cells.
• Premature Adrenarche: Detects mild, age-inappropriate elevations of adrenal androgens in young children, confirming early adrenal zone development.
• Cushing’s Disease: Identifies elevated androstenedione levels secondary to chronic ACTH hypersecretion from a pituitary adenoma.
• Ectopic ACTH Syndrome: Detects adrenal androgen excess driven by ACTH-secreting neuroendocrine tumors outside the pituitary gland.
• Primary Adrenal Insufficiency (Addison’s Disease): Detects abnormally low levels of androstenedione, indicating autoimmune or infectious destruction of the adrenal cortex.
• Secondary Adrenal Insufficiency: Identifies low androstenedione levels resulting from pituitary gland dysfunction and inadequate ACTH stimulation.
• Tertiary Adrenal Insufficiency: Detects low levels caused by hypothalamic disorders and impaired corticotropin-releasing hormone (CRH) secretion.
• Sheehan’s Syndrome: Identifies postpartum pituitary necrosis leading to panhypopituitarism and severely depleted adrenal androgens.
• Hypogonadotropic Hypogonadism: Detects low levels of androstenedione and other sex steroids in males with hypothalamic or pituitary failure.
• Hyperprolactinemia: Identifies moderate adrenal androgen elevations triggered by high prolactin levels, which can stimulate the adrenal cortex.
• Anorexia Nervosa: Detects suppressed adrenal and gonadal androgen levels associated with severe nutritional deprivation and metabolic stress.
• Exogenous Corticosteroid Suppression: Identifies low levels of endogenous androstenedione caused by the suppressive feedback of therapeutic steroid medications.
• Response to Anti-Androgen Therapy: Monitors the efficacy of treatments designed to lower or block androgen levels in patients with hirsutism or PCOS.
• Efficacy of Glucocorticoid Replacement: Evaluates the adequacy of steroid replacement therapy in suppressing excess androgen production in CAH patients.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that timely and accurate diagnostic results are critical for effective clinical decision-making and patient peace of mind. For specialized endocrine investigations like the Androstenedione test, our laboratory employs highly automated, high-throughput immunoassay systems that streamline the testing process while maintaining rigorous quality control. The standard turnaround time for Androstenedione testing at Dr. Essa Lab is typically 24 to 48 hours from the time of sample collection. Once the analysis is complete, the results undergo a multi-step verification process by our qualified clinical biochemists and consultant pathologists to ensure absolute accuracy. Patients are notified immediately via SMS and WhatsApp when their reports are ready. To enhance convenience, Dr. Essa Lab offers multiple secure methods for accessing reports. Patients can view and download their diagnostic reports directly from the official Dr. Essa Lab website or through our dedicated mobile application. Additionally, printed copies of the reports can be collected from any of our numerous diagnostic centers and collection points conveniently located across Karachi and other major cities. This seamless digital integration ensures that you and your referring physician can access your critical health data promptly, facilitating timely clinical management.

Androstenedione Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Adult Male Serum Levels	0.6 – 2.7 ng/mL (2.0 – 9.0 nmol/L)	Elevated: Adrenal tumors, CAH, anabolic steroid use. Decreased: Hypogonadism, Addison’s disease.
Adult Female Serum Levels	0.5 – 2.7 ng/mL (1.7 – 9.4 nmol/L)	Elevated: PCOS, Congenital Adrenal Hyperplasia, ovarian tumors. Decreased: Menopause, adrenal insufficiency.
Postmenopausal Female Levels	0.3 – 1.5 ng/mL (1.0 – 5.2 nmol/L)	Elevated: Ovarian stromal hyperthecosis, active adrenal neoplasms. Decreased: Panhypopituitarism.
Pediatric Levels (Pre-pubertal)	Less than 0.5 ng/mL (1.7 nmol/L)	Elevated: Premature adrenarche, classic or non-classic CAH. Decreased: Delayed puberty, adrenal hypoplasia.
Adrenal Cortex Function	Balanced synthesis of cortisol and adrenal androgens	Impaired synthesis (CAH, Addison’s) or autonomous overproduction (adrenocortical adenoma/carcinoma).
Ovarian Theca Cell Activity	Normal follicular phase androgen production	Hyperactivity (PCOS, stromal hyperthecosis) or neoplastic proliferation (Sertoli-Leydig cell tumors).
Pituitary-Adrenal Axis (ACTH)	Normal feedback regulation of adrenal steroidogenesis	Disrupted feedback (Cushing’s disease, ectopic ACTH-producing tumors, exogenous steroid suppression).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Androstenedione?

• Experienced Healthcare Professionals: Our laboratory is led by highly qualified consultant pathologists and clinical biochemists who ensure the highest standards of diagnostic accuracy.
• Patient-Focused Care: We prioritize patient comfort, safety, and confidentiality throughout the entire testing process, from registration to report delivery.
• Quality Diagnostic Services: Dr. Essa Lab is an ISO 9001:2015 certified diagnostic network, adhering to strict international quality control protocols and external quality assurance programs.
• Professional Reporting: All hormone assays undergo rigorous multi-level verification by senior laboratory specialists to guarantee reliable and clinically actionable reports.
• Modern Diagnostic Approach: We utilize state-of-the-art automated chemiluminescent immunoassay (CLIA) platforms, minimizing human error and maximizing analytical precision.
• Comfortable Environment: Our numerous diagnostic centers across Karachi offer clean, comfortable, and welcoming environments designed to make your visit stress-free.
• Convenient Location: With an extensive network of branches and collection points throughout Karachi and Sindh, finding a Dr. Essa Lab near you is simple and convenient.
• Commitment to Accurate Diagnosis: Established in 1987, Dr. Essa Lab has built over three decades of trust, delivering precise diagnostic insights that empower clinicians and patients alike.